During the past decade, Cancer Research & Prevention Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Research & Prevention Center" #1 sponsor was "Cell Genesys" with 2 trials, followed by "ARCA Biopharma, Inc." with 1 trials sponsored, "Cephalon" with 1 trials sponsored, "Millennium Pharmaceuticals, Inc." with 1 trials sponsored and "Puma Biotechnology, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Cancer Research & Prevention Center" are "Prostate Cancer" (2 trials), "Breast Cancer" (1 trials), "Cancer" (1 trials), "Catheter Occlusion" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Cancer Research & Prevention Center" in a lesser frequency.

Most popular intervention types in "Cancer Research & Prevention Center" are "Drug" (6 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alfimeprase" (1 trials), "Bortezomib" (1 trials), "Chemotherapy (Taxotere and prednisone)" (1 trials), "Chemotherapy (docetaxel and prednisone)" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Research & Prevention Center" are 3 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Cancer Research & Prevention Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Cancer Research & Prevention Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Research & Prevention Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".